Dr. Masoud Majed, MD

Dr. Majed practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.

Dr. Majed's NPI, 1225569577, was assigned on March 27, 2017. Dr. Majed graduated from Tehran University of Medical Sciences School of Medicine in 2009. Dr. Majed holds California license A192632.

Dr. Majed's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.

Dr. Majed's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Majed to 1 more group practice or clinic, 1 other site and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Majed practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Majed's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Majed is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Majed's licenses on file in 3 states: California, Missouri and Minnesota.

Dmand AI lists migraine and chronic headache among the conditions Dr. Majed treats.

CMS data shows 166 Medicare services from Dr. Majed across 3 procedure codes in 2024, for 31 Medicare patients. Medicare paid $7,736 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 31 Medicare patients who saw Dr. Majed in 2024. The largest group is under 65, with 17 patients. 65% of them have high blood pressure, and 61% have high cholesterol. 61% are also on Medicaid. Their average risk score is 2.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Majed's median patient age at 51, with 66% women.

In 2024, Dr. Majed wrote 73 Medicare Part D claims for 21 patients. 68% of them were for generic drugs. CMS names the drug for 27 of them, across 2 drugs with 11 or more claims each, at $108,326 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

Dr. Majed accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Majed as offering telehealth.

Dmand AI links 7 papers to Dr. Majed, published from 2015 to 2019. 2018 was the busiest year, with 4. Dr. Majed's most frequent co-authors are Andrew McKeon, MD, Eoin Paul Flanagan, MBCHB and Sean J. Pittock, MD.

CMS Open Payments shows 51 general payments to Dr. Majed from 8 drug and device companies from 2023 to 2025. Speaker and faculty fees make up the largest share, 49% of the total. Alexion Pharmaceuticals, Inc. paid the most, $13,702.

Dr. Majed graduated from Tehran University of Medical Sciences School of Medicine in 2009.

Dr. Majed is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.